The 1st Technofarmalkes 2019: Indonesian Health Tech Innovation

107

Jakarta – In accordance with the policy and national strategy 2015-2019, improving the competitiveness of the pharmaceutical industry and medical devices, resilience and national independence, should be strengthened by the development of the pharmaceutical industry and medical equipment in the country competitiveness inter alia through regulations that favor domestic industry, strengthening the domestic industry and the increased use of domestic products, increased resources, availability of raw materials, Health Technology Assessments (HTA), Health Technology Management (HTM), penelitian dan pengembangan farmasi dan alat kesehatan yang memenuhi standar.

Program Kefarmasian dan Alat Kesehatan berupaya untuk meningkatkan akses, autonomy, dan mutu sediaan farmasi dan alat kesehatan bagi pembangunan kesehatan. Salah satu bentuk upaya peningkatan akses, autonomy, dan mutu tersebut melalui diseminasi informasi, advokasi, dan fasilitasi lintas pemangku kepentingan, dengan kegiatan ini diharapkan para lintas program, lintas sektor, as well as associated partners can obtain the latest information in the field of pharmaceutical and medical devices, and collaborate on various inputs.

To achieve the above objective and in the framework of the ASEAN Economic Community 2015 which has been running especially in the medical equipment sector held "Seminar of Pharmaceutical and Medical Devices Sector" with the theme "The 1st Technofarmalkes 2019 : Indonesia Health Tech Innovation "on 10 s.d 11 September 2019.

This activity also as a step to the development of Innovation and Competitiveness of Domestic Products including pharmaceutical products and medical devices, innovative research, and bilateral trade policy instruments, regional, and international; Clinical trials of medical devices; and facilitation (business matching, sharing experience) akademisi-business-government-community-innovator (A-B-G-C-I). Dissemination of information through innovation, increasing competitiveness, financing, dan pelayanan kesehatan kepada pemangku kepentingan terkait serta mendorong kemandirian sediaan farmasi dan alat kesehatan produksi dalam negeri.

Penerima manfaat pada kegiatan ini adalah Akademisi, peneliti, dan pemegang Inovasi, Industri dan manufaktur sediaan farmasi dan alat kesehatan dalam negeri serta Praktisi di fasilitas pelayanan kesehatan, serta Pemangku kepentingan terkait.